MTVA MetaVia Inc: Earnings growth forecast for next year
MetaVia Inc's complete dependence on external laboratories for molecule synthesis defines its current business model. EPS growth prospects for the next fiscal year illustrate market expectations, where 5.70 captures the current value of the indicator. However, intense pressure from pharma behemoths and certification complexities create risks, while the asset's value is determined exclusively by the success of clinical trials, regardless of macroeconomic conditions.
Analytical breakdowns for MetaVia (MTVA)
- share price and consensus valuation forecast:
- company stock capitalization data:
- book capitalization indicators:
- debt and liquidity details:
- earnings and market ratios statistics:
MTVA - Company Net Income|Projected Future Earnings MetaVia Inc|MTVA - P/E Multiple|Future Price to Earnings MetaVia Inc.|MTVA - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple MetaVia|MTVA - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months MetaVia|MTVA - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months metaviatx.com|MTVA - Earnings per share increase in current year|Net earnings per share growth forecast for next year MetaVia Inc
Comprehensive company analysis:MTVA, MetaVia Inc
The 5.70 metric reflects the consensus forecast for earnings per share (EPS) growth over the coming year, measuring market expectations regarding yield growth rates. By analyzing this 12-month expected EPS growth chart, an investor can determine if the asset is overheated or confirm the fundamental strength of the business through the curve's dynamics. The positive trend here confirms the effectiveness of MetaVia Inc. (MTVA) expansion into the affordable computing segment and Thomson laptops.
Analysis of competing companies
BIIB (Biogen Corp) - Earnings growth forecast for next year|Neurocrine Corp (NBIX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year RGC|Earnings growth forecast for next year axsome.com (AXSM)|ACADIA Pharmaceuticals Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year XENE|Viking Pharma - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Supernus Corp SUPN|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year DNLI|HRMY (Harmony Biosciences Holdings, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year Biohaven Ltd (BHVN)|Net earnings per share growth forecast for next year Amylyx (AMLX)|Expected earnings per share growth for next year Trevi Corp TRVI|Praxis Precision Medicines - Expected earnings per share growth for next year|Projected earnings per share increase next year AVXL (anavex.com)|CBLL: Expected earnings per share growth for next year|PRTA: Net earnings per share growth forecast for next year|ALEC: Earnings growth forecast for next year|Annexon Biosciences Inc. (ANNX) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Omeros Corp|Projected earnings per share growth rate for next year NGNE (neurogene.com)|Earnings growth forecast for next year ACIU|VYGR - Expected net earnings per share growth next year|Neumora Therapeutics Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Scilex Holding Company, Inc. SCLX|TVGN - Net earnings per share growth forecast for next year|Expected earnings per share trend next year ACOG (Alpha Cognition)|Cognition Therapeutics (CGTX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Inhibikase Therapeutics Inc (IKT)|Net earnings per share growth forecast for next year Cassava|Expected earnings per share growth for next year Assertio Therapeutics (ASRT)|Earnings growth forecast for next year COYA|VTGN - Expected net earnings per share growth next year|Ovid Therapeutics - Expected earnings per share growth for next year|Projected earnings per share increase next year ABOS (Acumen Pharmaceuticals Inc.)|CervoMed Inc - Earnings growth forecast for next year|ATHE - Earnings growth forecast for next year|CLNN (clene.com) - Expected earnings per share growth for next year|PEPG (PepGen) - Net earnings per share growth forecast for next year|JUNS (Jupiter Neurosciences Inc) - Earnings growth forecast for next year|Relmada Therapeutics Inc (RLMD) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ANVS|Earnings growth forecast for next year gracetx.com (GRCE)|Firefly Neuroscience, Inc - Expected earnings per share growth for next year|Expected earnings per share trend next year KLTO|NeuroSense Therapeutics, Ltd. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Reviva Pharmaceuticals Holdings Inc. RVPH|NeurAxis, Inc (NRXS) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year HSDT|PASG (Passage Bio Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year Neuphoria (NEUP)|Net earnings per share growth forecast for next year Minerva Neurosciences, Inc. (NERV)|Expected earnings per share growth for next year Athira Pharma Inc ATHA|Addex Therapeutics, Ltd. - Expected earnings per share growth for next year|Projected earnings per share increase next year ALZN (Alzamend Neuro Inc.)|CYCN: Expected earnings per share growth for next year|PTIX: Net earnings per share growth forecast for next year|KTTA: Earnings growth forecast for next year|Cortigent (CRGT) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Avenue Therapeutics, Inc|Projected earnings per share growth rate for next year BCLI (BrainStorm Cell Therapeutics Inc.)|Earnings growth forecast for next year CARA|CHRO - Expected net earnings per share growth next year|Eliem Therapeutics Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year Intra-Cellular Therapies Inc. ITCI|LBPH - Net earnings per share growth forecast for next year|Expected earnings per share trend next year MRNS (Marinus Pharma)|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year neurobopharma.com (NRBO)|Net earnings per share growth forecast for next year Sage Therapeutics|Expected earnings per share growth for next year Synaptogenix Inc. (SNPX)|Earnings growth forecast for next year TRVN|VIGL - Expected net earnings per share growth next year|Anew Medical - Expected earnings per share growth for next year|Projected earnings per share increase next year CERE (cerevel.com)
